Skip to main content

Pituitary Apoplexy

  • Chapter
  • First Online:
Transsphenoidal Surgery

Abstract

Pituitary apoplexy is an acute clinical syndrome that occurs from the spontaneous hemorrhage and/or infarction of a pre-existing pituitary adenoma. Pituitary apoplexy arises most frequently in undiagnosed pituitary adenomas and is associated with worse outcomes than pituitary adenomas detected without acute clinical deterioration. The pathophysiology of pituitary apoplexy is not completely understood; however, it is thought to occur due to rapid tumor growth outstripping the blood supply, impingement of local blood vessels, and/or structurally and functionally abnormal intratumoral blood vessels that might be prone to hemorrhage. A variety of precipitating factors are associated with pituitary apoplexy including acute increases in blood flow, coagulative disturbances, pregnancy, and head trauma. Classic clinical symptoms of pituitary apoplexy include acute-onset headache, visual changes, cranial nerve palsy, and endocrine dysfunction; however, its clinical presentation and outcome are variable. Pituitary apoplexy is commonly managed surgically, although in certain cases when patients have mild symptomatology and comorbidities increasing the risk of surgery, conservative nonsurgical management with reabsorption of infarcted tissue over time can be considered. This chapter will outline the epidemiology, pathophysiology, risk factors, and management of pituitary apoplexy.

Patrick M. Flanigan and Arman Jahangiri contributed equally to this work.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Longrigg J. Greek medicine from the heroic to the Hellenistic age: a source book. New York: Bloomsbury Academic; 1998.

    Google Scholar 

  2. Bailey P. Pathological report of a case of acromegaly with special reference to the lesions in hypophysis cerebri and in the thyroid gland, and a case of hemorrhage into the pituitary. Philadelphia Med J. 1898;1:789–92.

    Google Scholar 

  3. Pearce JMS. On the origins of pituitary apoplexy. Eur Neurol. 2015:18–21. doi:10.1159/000431090.

  4. Brougham M, Heusner AP, Adams RD. Acute degenerative changes in adenomas of the pituitary body--with special reference to pituitary apoplexy. J Neurosurg. 1950;7:421–39.

    CAS  PubMed  Google Scholar 

  5. Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol. 2010;72:377–82.

    Google Scholar 

  6. Nishizawa S, Ohta S, Yokoyama T, Uemura K. Therapeutic strategy for incidentally found pituitary tumors (‘pituitary incidentalomas’). Neurosurgery. 1998;43:1344–48; discussion 1348–50.

    Google Scholar 

  7. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg. 1981;55:187–93.

    CAS  PubMed  Google Scholar 

  8. Kleinschmidt-DeMasters BK, Lillehei KO, Stears JC. The pathologic, surgical, and MR spectrum of Rathke cleft cysts. Surg Neurol. 1995;44:19–26; discussion 26–27.

    Google Scholar 

  9. Kilicli F, Dokmetas HS, Acibucu F. Sheehan’s syndrome. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2013;29:292–5.

    CAS  Google Scholar 

  10. Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 2007;109:63–70.

    PubMed  Google Scholar 

  11. Nielsen EH, et al. Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol. 2006;64:319–22.

    Google Scholar 

  12. Randeva HS, et al. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol. 1999;51:181–8.

    CAS  Google Scholar 

  13. Lubina A et al. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir. 2005;147:151–7; discussion 157.

    Google Scholar 

  14. Bonicki W, Kasperlik-Załuska A, Koszewski W, Zgliczyński W, Wisławski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir. 1993;120:118–22.

    CAS  PubMed  Google Scholar 

  15. Möller-Goede DL, Brändle M, Landau K, Bernays RL, Schmid C. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol Eur Fed Endocr Soc. 2011;164:37–43.

    Google Scholar 

  16. Biousse V, Newman N, Oyesiku N. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71:542–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Semple PL, De Villiers JC, Bowen RM, Lopes MBS, Laws ER. Pituitary apoplexy: do histological features influence the clinical presentation and outcome? J Neurosurg. 2006;104:931–7.

    PubMed  Google Scholar 

  18. Sibal L, et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004;7:157–63.

    PubMed  Google Scholar 

  19. Bujawansa S, et al. Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol. 2014;80:419–24.

    CAS  Google Scholar 

  20. Sharif-Alhoseini M, Rahimi-Movaghar V. Pituitary adenomas: a review. J Inj Violence Res. 2012;4:56.

    PubMed Central  Google Scholar 

  21. Capatina C, Inder WJ, Karavitaki N, Wass JAH. Management of endocrine disease: pituitary tumour apoplexy. Eur J Endocrinol. 2014:EJE–14–0794. doi:10.1530/EJE-14-0794.

  22. Semple PL, Webb MK, de Villiers JC, Laws ER. Pituitary apoplexy. Neurosurgery.2005;56:65–72; discussion 72–3.

    Google Scholar 

  23. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000;85:1789–93.

    CAS  PubMed  Google Scholar 

  24. Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus. 2004;16:E6.

    PubMed  Google Scholar 

  25. McDowell BD, et al. Demographic differences in incidence for pituitary adenoma. Pituitary. 2011;14:23–30.

    PubMed  PubMed Central  Google Scholar 

  26. Jankowski PP, et al. Pituitary tumor apoplexy in adolescents. World Neurosurg. 2015;83:644–51.

    PubMed  Google Scholar 

  27. Ranabir S, Baruah MP. Pituitary apoplexy. Indian J Endocrinol Metab. 2011;15:S188–96.

    PubMed  PubMed Central  Google Scholar 

  28. Semple PL, Jane JA, Lopes MBS, Laws ER. Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg. 2008;108:909–15.

    PubMed  Google Scholar 

  29. Bills DC et al. A retrospective analysis of pituitary apoplexy. Neurosurgery.1993;33:602–8; discussion 608–9.

    Google Scholar 

  30. Randall BR, Couldwell WT. Apoplexy in pituitary microadenomas. Acta Neurochir. 2010;152:1737–40.

    PubMed  Google Scholar 

  31. Jeffcoate WJ, Birch CR. Apoplexy in small pituitary tumours. J Neurol Neurosurg Psychiatry. 1986;49:1077–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Kuromatsu C. The fine structure of the human pituitary chromophobe adenoma with special reference to the classification of this tumor. Arch Histol Jpn Nihon Soshikigaku Kiroku. 1968;29:41–61.

    CAS  Google Scholar 

  33. Turner HE, et al. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159–62.

    CAS  PubMed  Google Scholar 

  34. Turner HE, et al. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol. 2000;165:475–81.

    CAS  PubMed  Google Scholar 

  35. Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol. 1972;67:109–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Xiao Z, Liu Q, Mao F, Wu J, Lei T. TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas. Int J Mol Sci. 2011;12:4165–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Jin Kim Y, Hyun Kim C, Hwan Cheong J, Min Kim J. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas. Tumori. 2011;97:639–46.

    PubMed  Google Scholar 

  38. Fukui S, et al. The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma. J Clin Neurosci Off J Neurosurg Soc Australas. 2003;10:320–4.

    CAS  Google Scholar 

  39. Lloyd RV, et al. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol. 1999;10:229–35.

    CAS  PubMed  Google Scholar 

  40. Briet C, Salenave S, Chanson P. Pituitary apoplexy. Endocrinol Metab Clin N Am. 2015;44:199–209.

    Google Scholar 

  41. Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008;23:75–90.

    PubMed  Google Scholar 

  42. Kruse A, Astrup J, Cold GE, Hansen HH. Pressure and blood flow in pituitary adenomas measured during transsphenoidal surgery. Br J Neurosurg. 1992;6:333–41.

    CAS  PubMed  Google Scholar 

  43. Brennan CF, Malone RGS, Weaver JA. Pituitary necrosis in diabetes mellitus. Lancet. 1956;268:12–6.

    Google Scholar 

  44. Holness RO, Ogundimu FA, Langille RA. Pituitary apoplexy following closed head trauma. Case report J Neurosurg. 1983;59:677–9.

    CAS  PubMed  Google Scholar 

  45. Uchiyama H, Nishizawa S, Satoh A, Yokoyama T, Uemura K. Post-traumatic pituitary apoplexy – two case reports. Neurol Med Chir (Tokyo). 1999;39:36–9.

    Google Scholar 

  46. Nagarajan DV, Bird D, Papouchado M. Pituitary apoplexy following anticoagulation for acute coronary syndrome. Heart Br Card Soc. 2003;89:10.

    CAS  Google Scholar 

  47. Willamowicz AS, Houlden RL. Pituitary apoplexy after anticoagulation for unstable angina. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 1999;5:273–6.

    CAS  Google Scholar 

  48. Nourizadeh AR, Pitts FW. Hemorrhage into pituitary adenoma during anticoagulant therapy. JAMA. 1965;193:623–5.

    CAS  PubMed  Google Scholar 

  49. Mattke AF, Vender JR, Anstadt MR. Pituitary apoplexy presenting as Addisonian crisis after coronary artery bypass grafting. Tex Heart Inst J Tex Heart Inst St Lukes Episcop Hosp Tex Child Hosp. 2002;29:193–9.

    Google Scholar 

  50. Absalom M, Rogers KH, Moulton RJ, Mazer CD. Pituitary apoplexy after coronary artery surgery. Anesth Analg. 1993;76:648–9.

    CAS  PubMed  Google Scholar 

  51. Shapiro LM. Pituitary apoplexy following coronary artery bypass surgery. J Surg Oncol. 1990;44:66–8.

    CAS  PubMed  Google Scholar 

  52. Cooper DM, et al. Pituitary apoplexy: a complication of cardiac surgery. Ann Thorac Surg. 1986;41:547–50.

    CAS  PubMed  Google Scholar 

  53. Weisberg LA. Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am J Med. 1977;63:109–15.

    CAS  PubMed  Google Scholar 

  54. Dökmetaş HS, et al. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly. J Endocrinol Investig. 1999;22:698–700.

    Google Scholar 

  55. Kılıçlı F, Dökmetaş HS, Gürelik M. Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma. Singap Med J. 2010;51:e179–81.

    Google Scholar 

  56. Lee DH, et al. Apoplexy of pituitary macroadenoma after combined test of anterior pituitary function. Endocr J. 2000;47:329–33.

    CAS  PubMed  Google Scholar 

  57. Matsuura I, Saeki N, Kubota M, Murai H, Yamaura A. Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test. Endocr J. 2001;48:493–8.

    CAS  PubMed  Google Scholar 

  58. Yoshino A et al. Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests. Acta Neurochir.2007;149:557–65; discussion 565.

    Google Scholar 

  59. Masago A, Ueda Y, Kanai H, Nagai H, Umemura S. Pituitary apoplexy after pituitary function test: a report of two cases and review of the literature. Surg Neurol. 1995;43:158–64; discussion 165.

    Google Scholar 

  60. Abe T, Ludecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol. 2001;145:137–45.

    Google Scholar 

  61. Bakiri F, et al. Pituitary apoplexy after somatostatin analogue administration: coincidental or causative? Clin Endocrinol. 2014;81:471–3.

    CAS  Google Scholar 

  62. Colao A, Auriemma RS, Pivonello R. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary. 2015;19:210–21. doi:10.1007/s11102-015-0677-y.

    Article  CAS  PubMed Central  Google Scholar 

  63. de Heide LJM, van Tol KM, Doorenbos B. Pituitary apoplexy presenting during pregnancy. Neth J Med. 2004;62:393–6.

    PubMed  Google Scholar 

  64. Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol. 2010;162:453–75.

    CAS  PubMed  Google Scholar 

  65. Cinar N, et al. Cavernous sinus invasion might be a risk factor for apoplexy. Pituitary. 2013;16:483–9.

    CAS  PubMed  Google Scholar 

  66. Jahangiri A, et al. Socioeconomic factors associated with pituitary apoplexy. J Neurosurg. 2013;119:1432–6.

    PubMed  Google Scholar 

  67. Findling JW, et al. Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab. 1981;52:95–7.

    CAS  PubMed  Google Scholar 

  68. Peter SA. Subclinical pituitary apoplexy. N Y State J Med. 1987;86:656–7.

    Google Scholar 

  69. Russell SJ, Miller KK. In: MD BS, MD BM, K B editors. Diagnosis and management of pituitary disorders. Humana Press; 2008. p. 353–75. At http://link.springer.com/chapter/10.1007/978-1-59745-264-9_19.

  70. Shimon I. In Turgut M, Mahapatra AK, Powell M, Muthukumar N, editors. Pituitary apoplexy. Springer Berlin Heidelberg; 2014. p. 49–54. at http://link.springer.com/chapter/10.1007/978-3-642-38508-7_7.

  71. Jahangiri A, et al. Incidence of headache as a presenting complaint in over 1000 patients with sellar lesions and factors predicting postoperative improvement. Clin Neurol Neurosurg. 2015;132:16–20.

    PubMed  Google Scholar 

  72. Gorczyca W, Hardy J. Microadenomas of the human pituitary and their vascularization. Neurosurgery. 1988;22:1–6.

    CAS  PubMed  Google Scholar 

  73. Johnston PC, Hamrahian AH, Weil RJ, Kennedy L. Pituitary tumor apoplexy. J Clin Neurosci Off J Neurosurg Soc Australas. 2015;22:939–44.

    Google Scholar 

  74. Veldhuis JD, Hammond JM. Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal. Endocr Rev. 1980;1:100–7.

    CAS  PubMed  Google Scholar 

  75. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL. Acute management of pituitary apoplexy--surgery or conservative management? Clin Endocrinol. 2004;61:747–52.

    Google Scholar 

  76. Jenkins TM, Toosy AT. Visual acuity, eye movements and visual fields. In: Turgut M, Mahapatra AK, Powell M, Muthukumar N, editors. Pituitary apoplexy. Heidelberg: Springer-Verlag; 2014. p. 75–88.

    Google Scholar 

  77. Turgut DM, Mahapatra AK, Powell M, Muthukumar N. Pituitary apoplexy. New York: Springer Science & Business Media; 2013.

    Google Scholar 

  78. Huang W-Y, et al. Pituitary adenoma apoplexy with initial presentation mimicking bacterial meningoencephalitis: a case report. Am J Emerg Med. 2009;27:517.e1–4.

    PubMed  Google Scholar 

  79. Wohaibi MA, et al. Pituitary apoplexy presenting as massive subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2000;69:700–1.

    CAS  PubMed  Google Scholar 

  80. Boellis A, di Napoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging. 2014;5:753–62.

    PubMed  PubMed Central  Google Scholar 

  81. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery. 1990;26:980–6.

    CAS  PubMed  Google Scholar 

  82. Kaplan B, Day AL, Quisling R, Ballinger W. Hemorrhage into pituitary adenomas. Surg Neurol. 1983;20:280–7.

    CAS  PubMed  Google Scholar 

  83. Arita K, et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg. 2001;95:897–901.

    CAS  PubMed  Google Scholar 

  84. Rajasekaran S, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol. 2011;74:9–20.

    Google Scholar 

  85. Quinones-Hinojosa A. Schmidek and sweet: operative neurosurgical techniques: indications, methods and results (Expert consult-online and print). Elsevier Health Sciences, 2012. At https://books.google.com/books?hl=en&lr=&id=4sKQSY-zdvgC&oi=fnd&pg=PP1&dq=Schmidek+and+Sweet:+Operative+Neurosurgical+Techniques+2-Volume+Set,+6th+Edition&ots=eXx07LErnT&sig=wHtTMWfozh6euF2c6g6L6nJxbZg.

  86. Rolston JD, Han SJ, Aghi MK. Nationwide shift from microscopic to endoscopic transsphenoidal pituitary surgery. Pituitary. 2015;19:248–50. doi:10.1007/s11102-015-0685-y.

    Article  Google Scholar 

  87. Seuk J-W, Kim C-H, Yang M-S, Cheong J-H, Kim J-M. Visual outcome after Transsphenoidal surgery in patients with pituitary apoplexy. J Korean Neurosurg Soc. 2011;49:339–44.

    PubMed  PubMed Central  Google Scholar 

  88. Pelkonen R, et al. Pituitary function after pituitary apoplexy. Am J Med. 1978;65:773–8.

    CAS  PubMed  Google Scholar 

  89. Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80:2190–7.

    CAS  PubMed  Google Scholar 

  90. Chacko G, et al. The clinical significance of MIB-1 labeling index in pituitary adenomas. Pituitary. 2010;13:337–44.

    PubMed  Google Scholar 

  91. Webb KM et al. Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery. 2003;53:1076–84;discussion 1084–5.

    Google Scholar 

  92. Walsh MT, Couldwell WT. Symptomatic cystic degeneration of a clinically silent Corticotroph tumor of the pituitary gland. Skull Base. 2010;20:367–70.

    PubMed  PubMed Central  Google Scholar 

  93. Vicente A, Lecumberri B, Gálvez MÁ. Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy. Endocrinol Nutr Engl Ed. 2013;60:582. e1–582.e12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manish K. Aghi MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Flanigan, P.M., Jahangiri, A., Lee, H.S., Aghi, M.K. (2017). Pituitary Apoplexy. In: Laws, Jr, E.R., Cohen-Gadol, A.A., Schwartz, T.H., Sheehan, J.P. (eds) Transsphenoidal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-56691-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56691-7_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56689-4

  • Online ISBN: 978-3-319-56691-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics